日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124

更正:Pourroy 等人,《各年龄段高剂量甲氨蝶呤:来自欧洲 HDMTX 注册研究的安全性、有效性和结局》,Cancers 2026, 18, 124

Pourroy, Bertrand; Aumente, Maria D; Koenecke, Christian; Stanulla, Martin; Ferreri, Andrés J M; Carillo, Thais M; Dandapani, Madhumita; Ritzmann, Timothy A; Barba, Pere; Chatelut, Etienne; Ingley, Katrina M; Morris, Emma; Schorb, Elisabeth; Liebig, Sven; Schwartz, Stefan; Howard, Scott C; Combs, Ryan; Tentoni, Nicolás; Lowe, Jennifer; Villanueva, Gabriela; Sampor, Claudia; Hwang, Miriam; Rizzari, Carmelo

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry

各年龄段高剂量甲氨蝶呤治疗:来自欧洲高剂量甲氨蝶呤注册研究的安全性、有效性和结果

Pourroy, Bertrand; Aumente, Maria D; Koenecke, Christian; Stanulla, Martin; Ferreri, Andrés J M; Murciano-Carillo, Thais; Dandapani, Madhumita; Ritzmann, Timothy A; Barba, Pere; Chatelut, Etienne; Ingley, Katrina M; Morris, Emma; Schorb, Elisabeth; Liebig, Sven; Schwartz, Stefan; Howard, Scott C; Combs, Ryan; Tentoni, Nicolás; Lowe, Jennifer; Villanueva, Gabriela; Sampor, Claudia; Hwang, Miriam; Rizzari, Carmelo

Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays.

卡氏肺囊虫肺炎:KEX1、MSG1 和 MSG2 作为细胞因子释放试验中的关键抗原的潜力

Neumann F A Ottilie, Müller Markus, Mattert Gregor, Liebig Sven, Herbst Victor, Zapf Dorinja, Kiderlen Til R, Linke Christian, Arp Franziska, Deckert P Markus, Lüth Stefan, Schwarzlose-Schwarck Sandra, Dammermann Werner, Reinwald Mark

Histone deacetylase 5 regulates the inflammatory response of macrophages

组蛋白去乙酰化酶5调节巨噬细胞的炎症反应

Poralla, Lukas; Stroh, Thorsten; Erben, Ulrike; Sittig, Marie; Liebig, Sven; Siegmund, Britta; Glauben, Rainer